Junta editorial

Dr. Carlos Vallejos-Sologuren is Doctor in Medicine, Professor of Medicine at the Universidad Peruana Cayetano Heredia, Principal Member of the National Academy of Medicine and Founding Director of AUNA, a private healthcare network in Peru. He was Director of the Peruvian National Institute of Neoplastic Diseases (INEN), starting a new approach to fight cancer in Peru by decentralizing specialized healthcare services and elaborating strategic plans to fight, prevent and manage cancer. In 2006 he was designated Minister of Health in Peru. During his administration he launched the Peruvian cancer control plan, developing a strategy of “budget by results” (allowing an efficient Public Expenditure) and the incorporation of the universal insurance to cover the treatment of low-income patients.

Dr. Carlos Vallejos Sologuren has had a very productive scientific career; he founded in 1996 the Peruvian Society of Medical Oncology and was its first President.  In 1998 he was appointed as regional delegate of the “Federation Latinoamericana de Sociedades de Cancerología”.  In 2000 he was designated Principal Investigator for Eastern Cooperative Oncology Group (ECOG); in 2003, he was chosen as Regional Representative of the “European Society for Medical Oncology” (ESMO); in 2008, he was appointed as Vice-President of the Executive Committee of the World Health Organization until 2009.  In 2010 he has been named Board Member of the International Affair Committee of the American Society of Clinical Oncology-ASCO and in that same year, he became a member of the International Education Council of Molecular Targeted Therapy of Cancer (MTTC) as Chair. In 2011 became elected President of the Latin America & Caribbean Society of Medical Oncology (SLACOM). He has participated in more than 200 publications related to cancer research in journal articles, abstract and books.  Dr. Vallejos Sologuren has received more than 46 awards and recognitions, including the “Distinguished Alumnus Award 2006” from The University of Texas M.D. Anderson Cancer Center.